Demonstration of flow and platelet dependency in a ferric chloride- induced model of thrombosis

Journal of Cardiovascular Pharmacology

Volumn 33, Issue 5, 1999, Pages 718-725

  Lockyer, Simon ^a,b   Kambayashi, Jun Ichi ^a  

^a Otsuka America Pharmaceutical   (United States)

^b OTSUKA PHARMACEUTICAL DEVELOPMENT AND COMMERCIALIZATION INC   (United States)

Author keywords

Blood flow; Ferric chloride; Platelets; Thrombosis

Indexed keywords

ACETYLSALICYLIC ACID; FERRIC CHLORIDE; HEPARIN; HIRUDIN; TRANEXAMIC ACID;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BLOOD FLOW; DOSE RESPONSE; NONHUMAN; PRIORITY JOURNAL; RABBIT; THROMBOCYTE; THROMBOCYTE AGGREGATION; THROMBOCYTOPENIA; THROMBOGENESIS; THROMBOSIS; THROMBUS;

ANIMALS; ANTIFIBRINOLYTIC AGENTS; ANTITHROMBINS; ARTERIAL OCCLUSIVE DISEASES; ASPIRIN; BLOOD PLATELETS; CAROTID ARTERY DISEASES; CAROTID ARTERY, COMMON; FERRIC COMPOUNDS; FIBRINOLYTIC AGENTS; HEPARIN; HIRUDINS; IMMUNE SERA; LIGATION; MALE; PLATELET AGGREGATION; PLATELET AGGREGATION INHIBITORS; RATS; RATS, SPRAGUE-DAWLEY; REGIONAL BLOOD FLOW; THROMBOSIS; TRANEXAMIC ACID;

EID: 0032916663     PISSN: 01602446     EISSN: None     Source Type: Journal    
DOI: 10.1097/00005344-199905000-00007     Document Type: Article

References (27)

1. Kurz KD, Main BW, Sandusky GE. Rat model of arterial thrombosis induced by ferric chloride. Thromb Res 1990;60:269-80.
2. Roux R, Carteaux J, Hess P, Falivene L, Clozel J. Experimental carotid thrombosis in the guinea pig. Thromb Haemost 1994;71: 252-6.
3. Tomikawa M. Pathophysiological studies on lactic acid-induced pulmonary thrombosis in the rat: I. effect of heparin, acetylsalicylic acid, urokinase and tranexamic acid. Thromb Diath Haemorrh 1975;34:145-58.
4. Folts JD, Crowell EB, Rowe GG. Platelet aggregation in partially obstructed vessels and its elimination with aspirin. Circulation 1976;54:365-70.
5. Klement P, Borm A, Hirsh J, Maraganore J, Wilson G, Weitz J. The effect of thrombin inhibitors on tissue plasminogen activator induced thrombolysis in a rat model. Thromb Haemost 1992;68: 64-8.
6. Massad L, Plotkine C, Capdeville C, Boulu RG. Electrically induced arterial thrombosis model in the conscious rat. Thromb Res 1987;48:1-10.
7. Kordenat RK, Kezdi P, Stanley EL. A new catheter technique for producing experimental coronary thrombosis and selective coronary visualisation. Am Heart J 1972;83:360-4.
8. Lenfors S, Marberg L, Wilkström U. A new rat model of arterial thrombosis with a platelet-rich head and an erythrocyte-rich tail: thrombolysis experiments with specific thrombin inhibition. Blood Coagul Fibrinol 1993;4:263-71.
9. Vogel GM, van Amsterdam RG, Zandberg P, et al. Two new closely related rat models with relevance to arterial thrombosis - efficacies of different antithrombotic drugs. Thromb Haemost 1997;77:183-9.
10. Friedman MF, Van der Bovenkamp EJ. The pathogenesis of a coronary thrombus. Am J Pathol 1966;48:19-44.
11. Dujovny M, Rozario R, Kossovsky N. Antiplatelet effect of dimethyl sulfoxide, barbiturates and methyl prednisolone. Ann N Y Acad Sci 1983;411:234-44.
12. Joist JH, Cazenave J-P, Mustard JF. The effect of barbituric acid derivatives on platelet function in vitro and in vivo. Thromb Diath Haemorrh 1973;30:315-26.
13. Broersma RJ, Kutcher LW, Heminger EF. The effect of thrombin inhibition in a rat arterial thrombosis model. Thromb Res 1991;64: 405-12.
14. 2 in plasma of whole-body irradiated rats in the early stage of irradiation. Prostaglandins Leukot Essent Fatty Acids 1990;41:39-43.
15. Schumacher WA, Steinbacher TE, Heran CL, Seiler SM, Michel IM, Ogletree ML. Comparison of thrombin active site and exosite inhibitors in experimental models of arterial and venous thrombosis and bleeding. J Pharmacol Exp Ther 1993;267:1237-42.
16. Lewis SD, Ng AS, Lyle EA, et al. Inhibition of thrombin by peptides containing lysyl-α-keto carbonyl derivatives. Thromb Haemost 1995;74:1107-12.
17. Eitzman DT, Chi L, Saggin L, Schwartz RS, Lucchesi BR, Fay WP. Heparin neutralization by platelet-rich thrombi. Circulation 1994;89:1523-9.
18. Lyle EM, Lewis SD, Lehman ED, Gardell SJ, Motzel SL, Lynch JJ. Assessment of thrombin inhibitor efficacy in a novel rabbit model of simultaneous arterial and venous thrombosis. Thromb Haemost 1998;79:656-62.
19. Schumacher WA, Heran CL, Steinbacher TE. Superior activity of a thromboxane receptor antagonist as compared with aspirin in rat models of arterial and venous thrombosis. J Cardiovasc Pharmacol 1993;22:526-33.
20. Reyers I, Mussoni L, Donati MB. Failure of aspirin at different doses to modify experimental thrombosis in rats. Thromb Res 1980;18:669-74.
21. Livio M, Benigni A, Zoja C, et al. Differential inhibition by aspirin of platelet thromboxane and renal prostaglandins in the rat. J Pharmacol Exp Ther 1989;248:334-41.
22. Burke SE, Lefer AM, Nicoloau KC. Responsiveness of platelets and coronary arteries from different species to synthetic thromboxane and prostaglandin endoperoxide analogues. Br J Pharmacol 1983;78:287-92.
23. Butler KD, Ambler J, Dolan S, Giddings MD, Talbot MD, Wallis RB. A non-occlusive model of arterial thrombus formation in the rat and its modification by inhibitors of platelet function, or thrombin activity. Blood Coagul Fibrinol 1992;3:155-65.
24. Packham MA, Mustard JF. Platelet adhesion. Prog Haemost Thromb 1984;7:211-87.
25. Grabowski EF. Thrombolysis, flow, and vessel wall interactions. J Vasc Intervent Radiol 1995;6:25S-9S.
26. Grabowski EF. Platelet aggregation in flowing blood at a site of injury to an endothelial cell monolayer: quantitation and real-time imaging with the TAB antibody. Blood 1990;75:390-8.
27. Kroll MH, Hellums JD, McIntire LV, Schafer AI, Moake J. Platelets and shear stress. Blood 1996;88:1525-41.